Continuing Professional Development

The ECPM Continuing Professional Development (CPD) platform provides accredited high quality educational programs to support continuing medical education and professional development for physicians, and pharmaceutical industry, regulatory and university professionals. As such, its primary intention is to provide up-to-date knowledge on current trends in drug development and to train drug development professionals for their next career step. Additionally, it offers a platform to share knowledge with colleagues and discuss with experts face-to-face. Our services include a broad range of CPD short courses that cover all skills across the drug development process. These CPD short courses count towards the Master program, yet they are also a stand-alone offer and can be booked individually to shape your professional skills and are offered in the following formats:

Short Courses/Workshops - A range of interactive onsite short courses/workshops. These cover a broad curriculum within the drug development process - from educational seminars to soft skills.

Frontiers in Drug Development Seminar - One day onsite seminars on new trends in drug development science.

E-Learning -Selected e-learning courses that provide an interactive environment for self-paced learning and can be booked at any time.

Study Trips - Yearly international study trips. A total of six study half-days are planned, which allow participants to experience a mix of theory and visits to institutions.

Courses offered by other Course Providers - Co-organized courses with other institutions, such as the University Hospital of Basel or partner universities. In addition, students also have the opportunity to choose courses offered by PharmaTrain Recognized Course Providers.

If you are interested in receiving information about our courses please subscribe to our ECPM newsletter.

16.11.2020 08:00

Ethical and Legal Aspects of Clinical Trials

More Information

Course Description

The implementation of clinical research projects requires conscientious review of research projects not only in terms of their scientific quality but also in regard to their ethical adequacy and appropriateness. How can we balance the risk-benefit of our projects? Given the importance of ethics for the conduct of drug development and research, it should come as no surprise that many different professional associations, government agencies, and universities have adopted specific codes, rules, and policies relating to research ethics.

Each of these aspects will be carefully considered and discussed in the context of international and national principles and guidelines. These issues need to be carefully adhered to strengthen the health of the clinical trial enterprise to the benefit of patients and the overall health of the public. During our course, representatives from different institutions will introduce and discuss the most important concepts, tools, principles, and methods that can be useful in approaching and resolving ethical dilemmas. Realworld examples and case studies will be introduced and discussed.

Course Program

Day 1
The Evolution of Biomedical Research Ethics / Risk-Benefit Considerations of Research Interventions / Role of Ethics Committees / Successful Submission to an Ethics Committee / Coordinating Human Research in Switzerland / How to Design an Informed Consent / Ethical Review Systems in Europe and European Legislation / Ethics Committees’ Role in Reviewing Safety Information

Day 2
Equipoise / Transparency in Clinical Trials / Common Technical Document / Confidentiality and Intellectual Property / Personal Data Protection / Inducement in Clinical Research – from Recruitment Advertisement to Subject Compensation / Role of Patient Organisations in Clinical Trials (EUPATI) / Public Health Ethics (incl. biobanks)

Day 3
Ethical Aspects of Clinical Research in Children / Informed Consent Process in Pediatric Patients / Clinical Research in Vulnerable Populations / Misconduct and Fraud, Research Integrity / ICH E6 Regulation / Legal and Ethical Framework for Genetic Testing

Learning Outcomes

By the end of the course, students will be able to:

  • Name key principles of ethical considerations during clinical research and development
  • Discuss ethical concerns for designing, conducting and reporting the results obtained through the conduct of clinical trials
  • Understand international and national principles and guidelines which have to be followed when performing clinical trials

Course Faculty

Dr. Jane Barrett
Dr. Julia Bielicki
Dr. Corina Braem
Dr. Thomas Gruberski
Nienke Jones
Dr. Peter Kleist
Dr. Ingrid Klingmann
Dr. Sabine Österle
Dr. Nicole Probst
Magalie Wasem-Tréguer
Dr. Beat Widler

Target Audience

All pharmaceutical and health care professionals who are interested in getting a deeper understanding of ethical and legal aspects in medicines development.

Course Language

English

Course Credits

The course including assessment provides 2 ECTS credits.

Course Date and Venue

November 16-18, 2020
Online via Zoom

Course Fee

Course fee including certificate, electronic course material and coffee breaks is CHF 2000.
A reduced fee applies to participants from academia and nonprofit organizations.

Cancellation Policy

Refund of fee will be given if cancellation is received in written format () before the deadline for registration, after this date no refund can be given.

Deadline for Registration

October 15, 2020

Course Organizer

This course is organized by the European Center of Pharmaceutical Medicine.

Project Management in Clinical Study Operations
25.11.2020 08:00

Project Management in Clinical Study Operations

More Information

Course Description

This course teaches the general principles and theory of project management in the context of clinical study operations. Clinical trials are highly complex enterprises that demand professional management at every stage and level. Project managers in clinical study operations take on many challenges including multiple stakeholders, budget control and stringent quality and regulatory requirements. In a workshop setting, participants will learn all essential tools for the successful planning, execution, monitoring and controlling of clinical study activities through highly interactive exercises and discussions.    

Main topics are: stakeholder management, roles and responsibilities of the project manager and the team, Work Breakdown Structure, project schedule and time management, resource management, quality assurance and quality control, risk management strategies, communication processes.

Learning Objectives

  • Define a project in the context of a clinical trial  
  • Discuss the role and responsibilities of a project manager and how the role can change  
  • Define a scope statement as the basis for further project planning, execution and/or monitoring and controlling activities  
  • Conduct a stakeholder analysis, discuss what is needed to  keep stakeholders aligned to support the project and develop reports to  keep stakeholders informed  
  • Organize the team’s work by developing and managing a Work Breakdown Structure (WBS)  
  • Create and manage a project schedule  
  • Define roles and responsibilities of team members, estimate the work efforts and discuss procurement options  
  • Identify the roles and functions of quality assurance and quality control  
  • Develop a project budget (forecast)  
  • Address potential threads to a project and develop a risk management strategy and plan  
  • Manage changes and anticipate how this impacts the schedule, quality, resources and budget  
  • Discuss the communication process

Credits

2 ECTS

Fee

1500 CHF

Date and Venue

September 2-4, 2020
University Hospital of Basel

Course Organizer and Registration

This course is organized by the Clinical Trial Unit (CTU), University Hospital of Basel - dkf.unibas.ch - in collaboration with the European Center of Pharmaceutical Medicine, University of Basel.
Course registration

ECPM Presentation and communicationSkill
22.02.2021 08:00

Presentation and Communication Skills

More Information

Course Description

The Presentation and Communication Skills course offers an intense two-day interactive, hands-on program designed to build and expand essential presentation skills, persuasive power, and personal presence. The course is designed for professionals who want to improve their personal communication skills, become more persuasive, and increase their effectiveness at work.

Course Program

The program includes theoretical background sessions and is enriched with exercises and presentation rehearsals

  • Illustrating the Power of Structure
  • Messaging Tools and Practice
  • Using the Body: Posture and Gesture

Learning Outcomes

At the end of the course, the participants should understand how to:

  • Speak effectively to groups of any size
  • Use body language to enhance messages
  • Conquer stage fright, nervousness and anxiety
  • Control question and answer sessions
  • Employ visual aids
  • Take control of a room and command attention

Participants will also have the opportunity to work on an upcoming or recent presentation to apply their understanding.

Course Faculty

TBA

Target Audience

The courses are for experienced professionals who want to improve their personal communication skills, become more persuasive, and increase their effectiveness at work.

Course Language

English

    Course Credits

    The course including assessment provides 2 ECTS credits.

    Course Date and Venue

    February 22-23, 2021
    University of Basel

    Course Fee

    Course fee including certificate, electronic course material and coffee breaks is CHF 1800.
    A reduced fee applies to participants from academia and nonprofit organizations.

    Cancellation Policy

    Refund of fee will be given if cancellation is received in written format () before the deadline for registration, after this date no refund can be given.

    Deadline for Registration

    February 1, 2021

    Course Organizer

    This course is organized by the European Center of Pharmaceutical Medicine.

    Registration
    15.03.2021 08:00

    Scientific Medical Writing

    More Information

    Course Description

    Brush up your scientific and medical writing skills. Learn how to structure scientific papers and reports and write a clear and informative scientific text. This course provides a comprehensive overview of the strategic scientific and medical writing field and offers hands-on training in writing and analyzing scientific texts.

    Course Program

    This course will cover:

    • What is the correct strategic approach to writing successful documents
    • How to convey a message to the target audience
    • How to produce high-quality documents
    • What are the requirements to reach a successful outcome
    • Ethics of scientific writing
    • Practical work with multiple exercises

    Learning Outcomes

    By the end of the course, students will be able to:

    • Know key elements of good medical and scientific writing
    • Critically appraise texts and identify elements of poor writing
    • Convert some examples of poor writing to good scientific writing
    • Reproduce the most important aspects of good medical and scientific writing
    • Improve own texts

    Course Faculty

    Dr. Silvia M. Rogers, MEDIWRITE, Basel, Switzerland

    Target Audience

    This course is for all professionals (native or non-native English speakers) who intend to improve their scientific medical writing skills.

    Course Language

    English

    Course Credits

    The course including homework provides 1 ECTS credit.
    100 FPH credit points in hospital pharmacy (accreditation to be submitted)

    Course Date and Venue

    March 15-16, 2021
    University of Basel

    Course Fee

    Course fee including certificate, electronic course material, book by Silvia Rogers and coffee breaks is CHF 1200.
    A reduced fee applies to participants from academia and nonprofit organizations.

    Cancellation Policy

    Refund of fee will be given if cancellation is received in written format () before the deadline for registration, after this date no refund can be given.

    Deadline for Registration

    February 22, 2021

    Course Organizer

    This course is organized by the European Center of Pharmaceutical Medicine.

    Registration
    ECPM Project Management in the Life Sciences Industry
    22.03.2021 08:00

    Project Management in the Life Sciences Industry

    More Information

    Course Description

    This course, offered in two parts of three days each, focuses on projects in the life sciences industry and the clinical trial setting, with the aim of bringing new treatments to patients successfully.

    These projects can range from early pre-clinical projects, to managing toxicology and Entry Into Human studies, large phase III clinical trials and post-marketing studies. All of them share a high complexity and require professional management at every level by experienced project managers who know the processes to reach the deliverables, can deal with multiple stakeholders simultaneously and deliver projects successfully often under a tight given budget and timelines.

    This highly interactive workshop setting includes a mixture of instructor led training and group work on real life cases. All templates and tools for planning, executing, managing & controlling as well as closing a project will be developed. In addition participants have the opportunity to discuss and work on an own project, identify its challenges and develop solutions or work on a model project provided by the course instructors.

    Course Program

    This course consists of two parts of three days each. A variety of teaching methods including lectures, exercises and interactive group discussions will be applied. A mandatory home assignment will complete the learning portfolio.

    The course covers the following topics:

    • Discussion of all project phases (initiation, planning, execution, monitoring & controlling, closure) and knowledge areas
    • Management of scope, time, cost, quality, team, communication, risk, procurement and stakeholders
    • Development of a project plan, starting from a project charter
    • Creation of documents and worksheets for managing clinical trials or other projects relating to pharmaceutical development
    • Discussion of Key Performance Indicators (KPIs) for project status
    • Discussion of Corrective Action Preventive Action (CAPAs) to prevent the project from getting off track

    Learning Outcomes

    At the end of the course, participants will

    • Understand the tasks and responsibilities of a project manager
    • Know the major project documents required for conducting projects successfully
    • Be acquainted with the tools to manage all knowledge areas throughout all project phases
    • Build, lead and manage effective project teams
    • Be familiar with the interactions needed with different project stakeholders
    • Have a series of templates and tools at hand
    • Be able to use and/or adapt these templates and tools within individual projects
    • Know how to practically apply different project management standards to all kinds of pharmaceutical development projects

    Course Faculty

    Adam Sobanski, MAIN5 Management Consulting, Frankfurt am Main, Germany

    Target Audience

    Specialists responsible for projects in the pharmaceutical industry, hospital or academic setting or regulatory authority. The course not only provides the tools and fundamentals for successful project management but also illustrates real life cases. Experienced managers are encouraged to bring their current issues so that solutions can be compiled during the course.

    Course Language

    English

      Course Credits

      The course including assessment provides 4 ECTS credits.

      Course Date and Venue

      March 22-24, 2021 and April 26-28, 2021
      University of Basel

      Course Fee

      Course fee including certificate, electronic course material, lunch and coffee breaks is CHF 3000.
      A reduced fee applies to participants from academia and nonprofit organizations.

      Cancellation Policy

      Refund of fee will be given if cancellation is received in written format () before the deadline for registration, after this date no refund can be given.

      Deadline for Registration

      February 15, 2021

      Course Organizer

      This course is organized by the European Center of Pharmaceutical Medicine.

      Registration
      Methodological concepts of health economics
      24.03.2021 08:00

      Fundamentals in Health Economics

      More Information

      Course Description

      This course intends to provide the participants with an understanding of the key principles and methodological concepts of health economics. The role of health-economic thinking in the drug development process is addressed. Two group exercises will complement lectures and discussions.

      Course Program

      The program includes theoretical background sessions and is enriched with exercises and in-group exercises

      • Basic economic concept and principles
      • Health economic evaluations principles and methods
      • Health economic evaluation in drug development
      • Health technology assessments and reimbursement
      • Health economic evaluation alongside clinical trials and the need for modelling
      • Budget impact analysis – relevance, principles, and relationship with cost-effectiveness analysis

      Learning Outcomes

      At the end of the course, the participants will

      • Understand the fundamental concepts of health economics.
      • Understand key principles of health economic evaluation.
      • Be able to assess and appraise a published health economic analysis according to guidelines and checklists.
      • Understand the importance of health economic/pharmacoeconomic methods and concepts for the drug development process, clinical trials, and post-marketing surveillance.
      • Understand how policymakers set priorities in health care and how health economic evaluations support this process
      • Understand the importance of health technology assessment in different health care systems.
      • Understand rational choice and priority setting using economic evaluation.

      Course Faculty

      Prof. Thomas D. Szucs, MD MPH MBA LLM
      Prof. Matthias Schwenkglenks, PhD MPH
      C. Simone Sutherland, MSc, PhD
      Joshua Ray, MSc

      Target Audience

      All pharmaceutical and health care professionals who are interested in getting a fundamental understanding of health economics and health economic evaluations in the context of drug development.

      Course Language

      English

        Course Credits

        The course including assessment provides 2 ECTS credits.

        Course Date and Venue

        March 24-25, 2021
        University of Basel 

        Course Fee

        Course fee including certificate, electronic course material and coffee breaks is CHF 1800.
        A reduced fee applies to participants from academia and nonprofit organizations.

        Cancellation Policy

        Refund of fee will be given if cancellation is received in written format () before the deadline for registration, after this date no refund can be given.

        Deadline for Registration

        February 28, 2021

        Course Organizer

        This course is organized by the European Center of Pharmaceutical Medicine.

        Registration
        01.04.2021 08:00

        Follow-on Drugs: Generic, Biosimilar & Non-Biological Similar Medicinal Products - MOVED TO 2021

        More Information

        This course has been moved to 2021. The new dates will be communicated as soon as possible.

        Course Description

        Gain insights into the scientific and regulatory basis of various types of follow-on drugs: generic, biosimilar and non-biological similar medicinal products and understand their significance in the life-cycle management of medicines.

        Course Language

        English

        Course Credits

        The course including assessment provides 2 ECTS credits.

        Course Fee

        Course fee including certificate, electronic course material and coffee breaks is CHF 1800.
        A reduced fee applies to participants from academia and nonprofit organizations.

        Cancellation Policy

        Refund of fee will be given if cancellation is received in written format () before the deadline for registration, after this date no refund can be given.

        Course Date and Venue

        This course has been moved to 2021. The new dates will be communicated as soon as possible.
        University of Basel  

        Deadline for Registration

        Will be communicated, once the new course dates are available.

        Course Organizer

        This course is organized by the European Center of Pharmaceutical Medicine.

        Registration
        ECPM Study Trip 2021
        ECPM Study Trip China 2021
        01.06.2021 00:10

        Study Trip 2021

        More Information

        The planned Study Trip has been postponed to 2021. Further information on the new dates will follow.

        Background

        After the trips to Singapore (2015, 2016), Israel (2017), Denmark (2018), and Canada (2019) the destination of the study trip 2021 is China.

        Brochure

        Study Trip Brochure (in German)

        Program

        A total of six study half-days are planned (theory and visits to institutions). The program will be available soon.

        • Introduction into the health system
        • Visits of hospitals
        • Insurance companies
        • Pharmaceutical industry

        Participants

        The study trip is intended for all experts working in public healthcare services. Minimum number of participants: 12 persons.

        Credits

        The trip provides 3 ECTS credits (rewarded after assignement has been accepted)

        Study Trip Fees

        Price varies according to country, registration and management via Max Künzi, 10% rebate for ECPM students. We reserve the right to change the program and/or the prices anytime.

        Registration

        For more information and registration please contact max.kuenzi@sagg-sahe.ch

        Contact

        Lic. iur. Max Künzi, MM | SAGG/SAHE | c/o Künzi Beratungen | Schachenstrasse 21 | Postfach 201 | 4702 Oensingen T (+41)(0)62 396 10 49 | F (+41)(0)62 396 24 10 | | www.sagg-sahe.ch | in cooperation with a travel agency.

        01.12.2021 11:45

        CAS Klinisch-genomische Medizin & Einführung in das Genetic Counseling - Mai bis Dezember 2020

        More Information

        Kursbeschreibung

        Die rasanten Fortschritte der molekularen Medizin beeinflussen immer mehr klinische Disziplinen und zwingen die Leistungserbringer, sich vermehrt mit diesen Themen auseinanderzusetzen. Auch Patientinnen und Patienten konfrontieren die Ärzte- und Apothekerschaft zunehmend mit Fragen zu genetischen Tests. Letztendlich wollen auch sie erfahren, welchen Einfluss die molekulare Medizin auf den klinischen  Entscheidungsprozess hat.

        Im Zertifikatskurs «Klinisch-genomische Medizin: Genetic Counseling» werden in komprimierter Art und Weise die wichtigsten Grundlagen der genomischen und personalisierten Medizin durch ausgewiesene Experten vermittelt. Die Teilnehmenden lernen, die Erkenntnisse molekularer Möglichkeiten klinisch einzuordnen und erfahren Wissenswertes über die zukünftigen und aussichtsreichsten  Anwendungsgebiete dieser faszinierenden Technologien.

        Modul A: Grundlagen der genomischen Medizin
        Modul B: Klinische Anwendungen der genomischen Medizin
        Modul C: Personalisierte Medizin und Public Health Genomics


        Weitere Informationen

        Leitung und Organisation
        Kursdetails und Teilnahmegebühren
        Lehrveranstaltungsplan

        Termine

        • Lehrveranstaltungsblock A1: Freitag-Samstag, 29.-30.Mai 2020 Unterrichtzeit: 8.30 –17.30 Uhr
        • Lehrveranstaltungsblock A2: Donnerstag –Samstag, 25.-27. Juni 2020 Unterrichtzeit: 8.30 –17.30 Uhr
        • Lehrveranstaltungsblock B1: Freitag, 21. August 2020 Unterrichtzeit: 8.30 –17.30 Uhr
        • Lehrveranstaltungsblock B2: Donnerstag–Samstag, 24.-26. September 2020 Unterrichtzeit: 8.30 –17.30 Uhr
        • Lehrveranstaltungsblock C1: Donnerstag–Samstag,15.-17.Oktober 2020 Unterrichtzeit: 8.30 –17.30 Uhr
        • Lehrveranstaltungsblock C2: Donnerstag–Samstag,19.-21. November 2020 Unterrichtzeit: 8.30 –17.30 Uhr
        • Lehrveranstaltungsblock B3: Donnerstag–Samstag, 03.-05. Dezember 2020 Unterrichtzeit: 8.30 –17.30 Uhr

        Kontakt

        Private Universität im Fürstentum Lichtenstein
        Margot Hermann

        +423 392 40 10

        ECPM Clinical Trial
        01.03.2022 14:08

        DAS Clinical Trial Practice and Management - November 2020 until September 2021

        More Information

        Course Description

        Successful clinical research requires clinical experience, but also extensive knowledge about all phases of the clinical research process, awareness of regulatory requirements as well as project management and leadership skills. The complex and highly competitive nature of clinical research, results in a growing need for well-trained clinical research professionals, not least those working as study coordinators, study managers, clinical monitors or clinical research assistants.

        Clinical research professionals usually start their careers with background knowledge from diverse graduate training often lacking structured training in clinical research. Still, they are facing highly demanding responsibilities in a complex, ever-evolving, interdisciplinary and often multinational environment. Fortunately, training at the postgraduate level is increasingly being recognized as essential to developing scientific, technical and interpersonal competencies to ultimately enhance the quality of clinical research.

        The goal of this program is to prepare trainees for the variety of management and leadership roles in different clinical research settings such as academia, pharmaceutical, medical device or biotech industry, clinical research organizations and regulatory agencies.

        Course Organizer and Registration

        This course is organized by the CTU Clinical Trial Unit, University Hospital of Basel.
        Course details and registration
         

         

        ECPM European University Network
        ECPM partner universities in the European University Network
        01.01.2023 08:10

        Other Courses by Pharmatrain

        More Information

        Join courses run by our partner universities in the European University Network, which offer training relevant to drug development sciences and the IMI PharmaTrain syllabus. For an overview of all PharmaTrain Recognized Course Providers please click here.

        E-Learning: Basics in Health Economics

        More Information

        Course Description

        This e-learning course provides an understanding of the key principles and methodological concepts of health economic evaluations. It is based on the well-established face-to-face course on health economics offered by the ECPM. The scientific content was developed by Prof. Thomas Szucs and Prof. Matthias Schwenkglenks as well as other specialists from the field.

        Learning Outcomes

        At the end of the course, the participants should be able to describe:

        • Fundamental concepts of health economics
        • Key elements of health economic evaluation
        • Assessment and analysis of a published health economic study
        • The importance of health economic/pharmacoeconomic methods and concepts for the drug development process, clinical trials, and post-marketing surveillance
        • How policymakers set priorities in health care and how health economic evaluations support this process

        Structure and Workload

        Our e-learning courses provide an interactive environment for self-paced learning. As soon as you have booked the course, the program is accessible online for you during one year at anytime. The course allows you to start/stop at any time. There will be several intermediate tests which will prepare you for the final test. The curriculum consists of nine lessons with a duration of approximately 60 to 90 minutes each. In addition, individual study, such as critical appraisal of specific literature is required (in total: approximately 30 hours). Each lesson is aimed to achieve a set of learning outcomes, using interactive techniques to help reinforce the taught topics.

        Course Language

        English

        Course Credits

        After successful completion of the e-learning course, 1 ECTS will be awarded (Certificate of Attendance from the University of Basel).

        Course Fee

        CHF 650
        A reduced fee applies to participants from academia and nonprofit organizations.

        Course Organizer

        This course is organized by the European Center of Pharmaceutical Medicine.

        Registration

        E-learning: Drug Safety and Pharmacovigilance

        More Information

        Course Description

        This e-learning course provides an understanding of the safety-related aspects within the drug development process. These range from early preclinical testing, risk/benefit assessment up to clinical adverse event signal detection and monitoring.

        Learning Outcomes

        At the end of the course, the participants should be able to describe:

        • The role of drug safety in the successful development and usage of a medicine to the benefit of patients
        • Which safety-related questions need to be answered in early and late drug development
        • Tools, techniques, and methodologies used in drug safety evaluation
        • What frequent pitfalls related to drug safety considerations occur and why they can lead to discontinuation of drugs in development, label changes or even withdrawal of drugs from the market after launch
        • How changes in safety assessment could become part of a new drug development paradigm

        Structure and Workload

        Our e-learning courses provide an interactive environment for self-paced learning. As soon as you have booked the course, the program is accessible online for you during one year at anytime. The course allows you to start/stop at any time. There will be several intermediate tests which will prepare you for the final test. The curriculum consists of nine lessons with a duration of approximately 60 to 90 minutes each. In addition, individual study, such as critical appraisal of specific literature is required (in total: approximately 30 hours). Each lesson is aimed to achieve a set of learning outcomes, using interactive techniques to help reinforce the taught topics.

        Course Language

        English

        Course Credits

        After successful completion of the e-learning course, 1 ECTS will be awarded (Certificate of Attendance from the University of Basel).

        Course Fee

        CHF 650
        A reduced fee applies to participants from academia and nonprofit organizations.

        Course Organizer

        This course is organized by the European Center of Pharmaceutical Medicine.

        Registration

        E-Learning: Personalized Health Care

        More Information

        Course Description

        This e-learning course provides an understanding of the key principles and methodological concepts of personalized drug development. The role of individualized treatment strategies is addressed, including all relevant clinical, ethical and governmental aspects.

        Learning Outcomes

        At the end of the course, the participants should be able to:

        • Understand the biological and clinical concepts of personalized medicine
        • Understand the benefits and pitfalls of individualized therapies for patients
        • Comprehend the basic elements of predictive and prognostic interventions
        • Understand the role of surrogate endpoints and clinically validated biomarkers in personalized medicine
        • Understand pharmacogenetic and pharmacogenomic implications
        • Be aware of the strategies of R&D processes with personalized drugs
        • Understand the economics challenges of personalized medicine and how policymakers set priorities in individualized health care
        • Determine legal, regulatory and ethical aspects of personalised medicine

        Structure and Workload

        Our e-learning courses provide an interactive environment for self-paced learning. As soon as you have booked the course, the program is accessible online for you during one year at anytime. The course allows you to start/stop at any time. There will be several intermediate tests which will prepare you for the final test. The curriculum consists of nine lessons with a duration of approximately 60 to 90 minutes each. In addition individual study, such as critical appraisal of specific literature is required (in total: approximately 30 hours). Each lesson is aimed to achieve a set of learning outcomes, using interactive techniques to help reinforce the taught topics.

        Course Language

        English

        Course Credits

        After successful completion of the e-learning course, 1 ECTS will be awarded (Certificate of Attendance from the University of Basel).

        Course Fee

        CHF 650
        A reduced fee applies to participants from academia and nonprofit organizations.

        Course Organizer

        This course is organized by the European Center of Pharmaceutical Medicine.

        Registration